During the past decade, Hopital Rangueil; Gastro Enterologie Et Nutrition conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Hopital Rangueil; Gastro Enterologie Et Nutrition" are "Colorectal Cancer" (1 trials), "Cytomegalovirus Infections" (1 trials) and "Esophageal Squamous Cell Carcinoma" (1 trials). Many other conditions were trialed in "Hopital Rangueil; Gastro Enterologie Et Nutrition" in a lesser frequency.

Most popular intervention types in "Hopital Rangueil; Gastro Enterologie Et Nutrition" are "Drug" (3 trials). Other intervention types were less common.

The name of intervention was led by "Atezolizumab" (2 trials), "5-FU/LV" (1 trials), "Atezolizumab Matching Placebo" (1 trials), "Bevacizumab" (1 trials) and "Cetuximab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hopital Rangueil; Gastro Enterologie Et Nutrition" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Hopital Rangueil; Gastro Enterologie Et Nutrition". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Hopital Rangueil; Gastro Enterologie Et Nutrition, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Hopital Rangueil; Gastro Enterologie Et Nutrition, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".